14 December 2022 in Angewandte Chemie International Edition
18 January 2024 in Angewandte Chemie International Edition
3 October 2024 in Aggregate
Donor‒acceptor covalent organic frameworks (D‒A COFs) have been regarded as promising materials for photocatalytic water splitting because of their tunable band gaps. However, their efficiency is hindered by fast charge recombination and low photostability. Herein, we proposed a donor structural engineering strategy for improving the photocatalytic activity of D‒A COFs to tackle these problems. Two benzothiadiazole‐based D‒A COFs (DHU‐COF‐BB and DHU‐COF‐BP) with distinct donors were prepared for photocatalytic H2 evolution reaction (HER). As a comparison, DHU‐COF‐TB without benzothiadiazole moieties was also designed and synthesized. Impressively, the photocatalytic H2 production rate of DHU‐COF‐BB reaches 12.80 mmol g−1 h−1 under visible light irradiation (≥420 nm), which was nearly 2.0 and 3.1 times higher than that of DHU‐COF‐BP (6.47 mmol g−1 h−1) and DHU‐COF‐TB (4.06 mmol g−1 h−1), respectively. In addition, the apparent quantum efficiency (AQE) of DHU‐COF‐BB was up to 5.04% at 420 nm. Photocatalytic and electrochemical measurements indicate that the enhanced hydrogen evolution activity of DHU‐COF‐BB can be ascribed to the introduction of appropriate benzene moiety into the donors, which increases the charge separation efficiency and thereby suppresses the electron‒hole recombination. Density functional theory (DFT) calculations revealed that both triphenylamine and benzothiadiazole units are the main active sites for HER over the DHU‐COF‐BB. This work provides new insight into the photocatalytic hydrogen production activity of D‒A COFs by a donor structural engineering strategy.
27 June 2023 in Angewandte Chemie International Edition
15 August 2023 in Biomaterials Science
Although immunotherapy has achieved great success in the treatment of a variety of tumors, its efficacy for glioblastoma (GBM) is still limited. Both the immunosuppressive tumor microenvironment (TME) and poor penetration of immunotherapeutic agents into tumors contributed to the poor anti-glioma immunity. Herein, we develop an injectable prodrug-loaded hydrogel delivery system with sono-activatable properties for sonodynamic therapy (SDT)-triggered immunomodulation for GBM treatment. The prodrug alginate hydrogels (APN), which contain semiconducting polymer nanoparticles (SPNs) and the NLG919 prodrug linked by singlet oxygen (1O2)-cleavable linkers, are in situ formed via coordination of alginate solution with Ca2+ in the TME. SPNs serve as sonosensitizers to produce 1O2 upon ultrasound (US) irradiation for SDT. The generated 1O2 not only induce immunogenic cell death, but also break 1O2-cleavable linkers to precisely activate the NLG919 prodrug. Antitumor immunity is significantly amplified due to the reversal of immunosuppression mediated by indolamine 2,3-dioxygenase-dependent tryptophan metabolism. This smart prodrug hydrogel platform potently inhibits tumor growth in orthotopic glioma-bearing mice. Collectively, this work provides a sono-activatable hydrogel platform for precise sono-immunotherapy against GBM.
1 December 2021 in Biomaterials